脂肪组织
甾醇调节元件结合蛋白
内质网
巨噬细胞极化
化学
内分泌学
肝X受体
内科学
胆固醇
胰岛素抵抗
白色脂肪组织
脂肪组织巨噬细胞
未折叠蛋白反应
细胞生物学
生物
甾醇
巨噬细胞
生物化学
转录因子
胰岛素
医学
体外
核受体
基因
作者
Jae‐Ho Lee,Sun Hee Lee,Eun‐Ho Lee,Jeong‐Yong Cho,Dae‐Kyu Song,Young Jae Lee,Taeg Kyu Kwon,Byung‐Chul Oh,Kae Won Cho,Timothy F. Osborne,Tae‐Il Jeon,Seung‐Soon Im
标识
DOI:10.1016/j.jare.2022.05.013
摘要
Sterol regulatory element binding protein (SREBP) cleavage-associating protein (SCAP) is a sterol-regulated escort protein that translocates SREBPs from the endoplasmic reticulum to the Golgi apparatus, thereby activating lipid metabolism and cholesterol synthesis. Although SCAP regulates lipid metabolism in metabolic tissues, such as the liver and muscle, the effect of macrophage-specific SCAP deficiency in adipose tissue macrophages (ATMs) of patients with metabolic diseases is not completely understood. Here, we examined the function of SCAP in high-fat/high-sucrose diet (HFHS)-fed mice and investigated its role in the polarization of classical activated macrophages in adipose tissue. Macrophage-specific SCAP knockout (mKO) mice were generated through crossbreeding lysozyme 2-cre mice with SCAP floxed mice which were then fed HFHS for 12 weeks. Primary macrophages were derived from bone marrow cells and analyzed further. We found that fat accumulation and the appearance of proinflammatory M1 macrophages were both higher in HFHS-fed SCAP mKO mice relative to floxed control mice. We traced the effect to a defect in the lipopolysaccharide-mediated increase in SREBP-1a that occurs in control but not SCAP mKO mice. Mechanistically, SREBP-1a increased expression of cholesterol 25-hydroxylase transcription, resulting in an increase in the production of 25-hydroxycholesterol (25-HC), an endogenous agonist of liver X receptor alpha (LXRα) which increased expression of cholesterol efflux to limit cholesterol accumulation and M1 polarization. In the absence of SCAP mediated activation of SREBP-1a, increased M1 macrophage polarization resulted in reduced cholesterol efflux downstream from 25-HC-dependent LXRα activation. Overall, the activation of the SCAP-SREBP-1a pathway in macrophages may provide a novel therapeutic strategy that ameliorates obesity by controlling cholesterol homeostasis in ATMs.
科研通智能强力驱动
Strongly Powered by AbleSci AI